Bupranolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263115This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 858YGI5PIT, chemically known as 2-propanol, 1-(tert-butylamino)-3-((6-chloro-m-tolyl)oxy)- (8ci) but generally known as bupranolol, which bears US NIH Compound Identifier 2475. Bupranolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bupranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05984MIG. The term BUPRANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules bupranolol in its Anatomical Therapeutic Chemical (ATC) Classification. BUPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bupranolol under HS 29221980 and SITC 51461. As of Q4 2014, BUPRANOLOL remains the US FDA Preferred Term for this commodity. Bupranolol bears US NLM identifiers UMLS ID C0006403 and NCI Concept Code C72615. SMILES: CLC1C(OCC(O)CNC(C)(C)C)CC(CC1)C.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.